Role of Endogenous Lipopolysaccharides in Neurological Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review outlining mechanistic pathways without systematic search or original human data.
PubMed 36552802 · doi:10.3390/cells11244038
What was done
This narrative review synthesizes published literature on the mechanistic pathways linking gut microbiota dysbiosis, intestinal barrier permeability, systemic translocation of bacterial lipopolysaccharide (LPS), and subsequent blood-brain barrier disruption to neuroinflammation and neurodegenerative pathology.
What was found
The abstract describes a qualitative pathogenic cascade and reports no numerical data, effect sizes, or statistical metrics. The proposed sequence involves gut dysbiosis causing increased intestinal permeability and systemic endotoxemia, which damages the blood-brain barrier, permits LPS and immune cell entry into the central nervous system, inappropriately activates microglia and astrocytes, elevates oxidative and nitrative stress, impairs mitochondrial function, and accelerates neuronal apoptosis.
Why it matters
It consolidates current theoretical and experimental models of the gut-brain axis, highlighting how peripheral bacterial endotoxins may drive central neuroinflammatory processes in neurodegenerative diseases.
Limits
The paper is a narrative review without systematic search methodology, study inclusion criteria, risk-of-bias evaluation, or quantitative meta-analysis. The abstract provides purely qualitative mechanistic assertions without presenting direct human clinical trial data or quantitative effect estimates.
Cited by
- supports LPS-driven immune activation and glial cell activation disrupt the blood-brain barrier, contributing to early-stage neurodegeneration.